Look for:

Our offer for

ELI LILLY AND COMPANY


ISIN:
US5324571083
WKN:
532457108

2021/10/26 18:54:04
Price
246.27 USD
Difference 0.50% (1.22)

General attributes

ISINUS5324571083
SymbolLLY
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)201,956 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)246.24 USD (100)
Ask (Ask size)246.47 USD (100)
Open244.50 USD
High248.37 USD
Low237.09 USD
Close (prev. day)245.05 USD
VWAP242.794683 USD
Volume (pcs)2,582,342
Trading volume627,111,643.66
Number of trades42,647
Last size100

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: ELI LILLY AND COMPANYPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2021/10/26 18:54:04
Price
246.27 USD
Difference 0.50% (1.22)

General attributes

ISINUS5324571083
SymbolLLY
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)201,956 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)246.24 USD (100)
Ask (Ask size)246.47 USD (100)
Open244.50 USD
High248.37 USD
Low237.09 USD
Close (prev. day)245.05 USD
VWAP242.794683 USD
Volume (pcs)2,582,342
Trading volume627,111,643.66
Number of trades42,647
Last size100

Performance and Risk

6m1Y3Y
Perf (%)+29.85%+72.11%+127.13%
Perf (abs.)+56.33+102.67+137.16
Beta0.630.590.69
Volatility28.0733.9532.47
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)243.20 USD (1,910,591)
Ø price 30 days | Ø volume 30 days (pcs.)233.47 USD (2,610,855)
Ø price 100 days | Ø volume 100 days (pcs.)240.60 USD (2,919,100)
Ø price 250 days | Ø volume 250 days (pcs.)204.72 USD (3,530,478)
YTD High | date275.87 USD (2021/08/17)
YTD Low | date161.78 USD (2021/01/07)
52 Weeks High | date275.87 USD (2021/08/17)
52 Weeks Low | date129.21 USD (2020/10/30)

All listings for ELI LILLY AND COMPANY

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2021/10/2617:35211.70 EUR0.84143
Vienna Stock Exchange2021/10/2517:32210.60 EUR0.002
Tradegate2021/10/2618:30211.00 EUR0.2562
Stuttgart2021/10/2618:52212.80 EUR0.028
SIX Swiss Exchange2021/10/0717:31200.00 CHF0.001
NYSE2021/10/2618:54246.27 USD627.1142,648
Munich2021/10/2608:02211.40 EUR0.001
London Stock Exchange2021/10/2516:33223.9136 CHF0.034
Hanover2021/10/2608:03211.40 EUR0.001
Hamburg2021/10/2614:00211.80 EUR0.013
Frankfurt2021/10/2617:02209.20 EUR0.166
Duesseldorf2021/10/2616:01206.80 EUR0.0010
Berlin2021/10/2608:08210.70 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=262&ID_TYPE_IMAGE_LOGO=2

Contact Details

ELI LILLY & CO.
- -
Lilly Corporate Center - 46285 Indianapolis
Telefon: 1-317-276-2000
Fax: -
E-mail: -

PDF Downloads

Company report: ELI LILLY AND COMPANYPDF Download

Company Profile

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. The Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. The Oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. The Immunology products include Olumiant and Taltz. The Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. The Other therapies include Bamlanivimab, Cialis, and Forteo.The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

Members of Management Board

Katherine BaickerMember of Board of Directors
Marschall RungeMember of Board of Directors
William KaelinMember of Board of Directors
Gabrielle Greene-SulzbergerMember of Board of Directors
Jackson TaiMember of Board of Directors
Jamere JacksonMember of Board of Directors
Jon FyrwaldMember of Board of Directors
Juan LucianoMember of Board of Directors
Karen WalkerMember of Board of Directors
Kimberly JohnsonMember of Board of Directors
Michael EskewMember of Board of Directors
Ralph AlvarezMember of Board of Directors
David A. RicksChairman of Managing Board
Daniel M. SkovronskyMember of Executive Committee
Alfonso G. ZuluetaMember of Executive Committee
Alonzo WeemsMember of Executive Committee
Anat AshkenaziMember of Executive Committee
Anat HakimMember of Executive Committee
Anne E. WhiteMember of Executive Committee
Diogo RauMember of Executive Committee
Edgardo HernandezMember of Executive Committee
Ilya YuffaMember of Executive Committee
Jacob Van NaardenMember of Executive Committee
Johna NortonMember of Executive Committee
Leigh Ann PuseyMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer